Based on previous studies, α-MG can reduce circulating TNF-α levels in acute liver injury and acute kidney injury (Fu et al. 2018; Eltahir et al. 2023), and our current work further indicated that α-MG may directly target TNF-α in Ang II-induced hypertension. This evidence concerns the gene TNF and acute kidney injury.